"Dedicated to discovery. Committed to Care. Sinclair Dermatology is Australia's leading centre for dermatology research and Victoria's largest dermatology clinic, treating more than 10,000 patients each year. We are affiliated with the University of Melbourne. Our team of dermatologists, plastic surgeons, hair transplant surgeons, trichologists, dermal therapists and nurses provide expert care for all skin, hair and nail conditions. Clinics include: General Dermatology 3D total body mole photography (Vectra WB360) Hair disorder Paediatric dermatology Plastic Surgery Hair Transplantation Surgery Dermal therapy and Medical Laser (Vascular, Pigmentation, Hair Removal) Hair salon & Trichology"

During the past decade, Sinclair Dermatology conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 24 clinical trials were completed, i.e. on average, 58.5% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 22 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sinclair Dermatology" #1 sponsor was "Pfizer" with 16 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Applied Biology, Inc." with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sinclair Dermatology" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Principia Biopharma Australia Pty Ltd." with 1 trials as a collaborator and "Shire" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sinclair Dermatology" are "Atopic Dermatitis" (12 trials), "Alopecia Areata" (6 trials), "Psoriasis" (6 trials), "Dermatitis, Atopic" (5 trials) and "Plaque Psoriasis" (3 trials). Many other conditions were trialed in "Sinclair Dermatology" in a lesser frequency.

Most popular intervention types in "Sinclair Dermatology" are "Drug" (39 trials), "Biological" (6 trials), "Other" (4 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "PF-06651600" (4 trials), "PF-06700841" (4 trials), "Lebrikizumab" (3 trials) and "PF-04965842 100 mg" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sinclair Dermatology" are 41 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sinclair Dermatology". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Sinclair Dermatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sinclair Dermatology, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".